Circulation journal : official journal of the Japanese Circulation Society · 2026
Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation - Post Hoc Subanalysis of the SUPPRESS-AF Trial.
СтатьяРандомизированное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Matsunaga-Lee Yasuharu, Egami Yasuyuki, Abe Masaru, Nohara Hiroaki, Kawanami Shodai, Yasumoto Koji, Okamoto Naotaka, Yano Masamichi, Nishino Masami, Masuda Masaharu, Sunaga Akihiro, Tanaka Nobuaki, Watanabe Tetsuya, Minamiguchi Hitoshi, Oka Takafumi, Minamisaka Tomoko, Kanda Takashi, Okada Masato, Kawasaki Masato, Matsuda Yasuhiro, Tanaka Koji, Makino Nobuhiko, Kida Hirota, Hikoso Shungo, Dohi Tomoharu, Inoue Koichi, Sotomi Yohei, Sakata Yasushi, OCVC-SUPPRESS-AF Investigators
Аннотация
BACKGROUND: Incomplete low-voltage area (LVA) ablation may confound evaluation of its true efficacy in persistent atrial fibrillation (AF). This post hoc subanalysis of the multicenter randomized SUPPRESS-AF trial assessed the impact of complete LVA ablation.
METHODS AND RESULTS: Patients with persistent AF and a left atrial (LA) LVA ≥5 cm2after pulmonary vein isolation were randomized to LVA ablation or no additional ablation. The primary endpoint was freedom from AF or atrial tachycardia recurrence, assessed by 24-h Holter and twice-daily electrocardiogram recordings. Outcomes were compared among 3 groups: no LVA ablation; complete LVA ablation; and incomplete LVA ablation. Among 341 patients, 170 underwent LVA ablation, including 37 with incomplete. LVA size was significantly larger in the incomplete than complete ablation group (22.0 vs. 12.2 cm2; P<0.001). Incomplete LVA ablation was not associated with increased arrhythmia recurrence. Arrhythmia-free survival did not differ significantly between the complete and no LVA ablation groups (hazard ratio [HR] 0.80; 95% confidence interval [CI] 0.56-1.13), including after propensity score matching (HR 0.76; 95% CI 0.51-1.15). However, a trend towards greater benefit of complete LVA ablation was observed with increasing LA diameter (Pinteraction=0.099).
CONCLUSIONS: Leaving LVA ablation incomplete to avoid complications appears reasonable. Although complete LVA ablation showed no overall superiority, LA enlargement may represent a clinically relevant factor for patient stratification.
METHODS AND RESULTS: Patients with persistent AF and a left atrial (LA) LVA ≥5 cm2after pulmonary vein isolation were randomized to LVA ablation or no additional ablation. The primary endpoint was freedom from AF or atrial tachycardia recurrence, assessed by 24-h Holter and twice-daily electrocardiogram recordings. Outcomes were compared among 3 groups: no LVA ablation; complete LVA ablation; and incomplete LVA ablation. Among 341 patients, 170 underwent LVA ablation, including 37 with incomplete. LVA size was significantly larger in the incomplete than complete ablation group (22.0 vs. 12.2 cm2; P<0.001). Incomplete LVA ablation was not associated with increased arrhythmia recurrence. Arrhythmia-free survival did not differ significantly between the complete and no LVA ablation groups (hazard ratio [HR] 0.80; 95% confidence interval [CI] 0.56-1.13), including after propensity score matching (HR 0.76; 95% CI 0.51-1.15). However, a trend towards greater benefit of complete LVA ablation was observed with increasing LA diameter (Pinteraction=0.099).
CONCLUSIONS: Leaving LVA ablation incomplete to avoid complications appears reasonable. Although complete LVA ablation showed no overall superiority, LA enlargement may represent a clinically relevant factor for patient stratification.